Skip to main content
. 2022 May 30;15:818696. doi: 10.3389/fnmol.2022.818696

TABLE 1.

An example of different types of brain tumor models and their relative features.

Glioma models
Brain tumor Type of model Features References
HGG CLX Glioma cell-lines T98 and U87 xenograft Jandial et al., 2018
HGG CLX Glioma cell-lines TG1 xenograft Fareh et al., 2012
HGG CLX/syngeneic Syngeneic glioma cell lines GL261 xenograft Ausman et al., 1970
HGG PDX/PDOX Xenograft of patient-derived GBM cells/neurospheres Sasaki et al., 2001; Joo et al., 2013; Kerstetter-Fogle et al., 2020
Pediatric tumors PDOX Xenograft of patient-derived tumor cells (from different type of pediatric glioma) Brabetz et al., 2018; Smith et al., 2020
HGG GEMM Pdgfb OE, Trp53–/– Hede et al., 2009
HGG GEMM Pdgfb OE, Ink4a/Arf–/–, Trp53–/–, Pten–/– Hambardzumyan et al., 2009
HGG GEMM K-Ras OE, Ink4a/Arf–/– Uhrbom et al., 2005
HGG GEMM EGFRvIII OE, Ink4a/Arf–/–, Pten–/– Zhu et al., 2009
HGG GEMM EGFRvIII OE, V12-Ras, Pten–/– Wei et al., 2006
HGG GEMM Nf1+/−, Trp53+/−, Pten+/− Kwon et al., 2008
HGG GEMM H-Ras-V12 OE, Akt OE, Trp53+/− Marumoto et al., 2009
LGG GEMM NrasG12V OE, Idh1R132H OE, shAtrx, shTrp53 Núñez et al., 2019
HGG GEBO EGFRvIII OE, EGFR OE, CDKN2A–/–/CDKN2B–/– or NF1–/–, TP53–/–, PTEN–/– Bian et al., 2018
HGG GEBO H-RasG12V OE, TP53–/– Ogawa et al., 2018
GBM PDO Patient-derived organoid Jacob et al., 2020
Drosophila
GBM Transgenic dEGFRλ, dp110CAAX, dPTEN, dRas85DN17, dRas85DV12, dRafGOF OE, dPTEN dsRNA Read et al., 2009, 2013
GBM Transgenic dRafGOF, hFGFR3-hTACC3, dEGFRACT, dPI3KACT Chen et al., 2018
Zebrafish
GBM Transgenic HRASG12V, KRASG12V EGFRvIII, BRAFV600E OE Mayrhofer et al., 2017
Glioma Transgenic KRASG12V OE Ju et al., 2015
Glioma Transgenic DAAkt1, DARac1 OE Jung et al., 2013
HGG/MPNSTs Knockout nf1a+/−; nf1b–/–; tp53e7/e7 Shin et al., 2012
GBM CLX Glioblastoma cell line U373-MG with shRacs or Racs OE Xenograft Lai et al., 2017
GBM CLX Glioblastoma cell line U87 and its derived cancer stem cells Xenograft Yang et al., 2013a
GBM CLX Glioblastoma cell lines U87 and U373 Xenotransplantation alone or with Mesenchymal stem cells Breznik et al., 2017
GBM PDX Primary GBM-derived cells xenografts Rampazzo et al., 2013
GBM PDX glioblastoma GBM9 cells xenografts into prkdc–/–, il2rga–/– Yan et al., 2019

Medulloblastoma models

MB subgroup Type of model Features References

WNT GEMM Ctnnb1+/−; TP53–/– Gibson et al., 2010
WNT PDOX Xenograft of patient-derived tumor cells Brabetz et al., 2018; Smith et al., 2020
SHH GEMM Ptch1 +/− Goodrich et al., 1997
SHH GEMM Ptch1 + ⁣/−, Trp53–/– Wetmore et al., 2001
SHH GEMM Ptch1+/−, Cdkn2c–/– Uziel et al., 2005
SHH GEMM SmoA2 OE Dey et al., 2012
SHH GEMM Sufu+/−, Trp53–/– Lee et al., 2007
SHH GEMM Trp53–/– with gPtch1.1/Cas9 Zuckermann et al., 2015
Adult SHH GEMM SmoM2 OE, truncated BRPF1 OE Aiello et al., 2019
SHH Orthotopic xenograft MYCN OE in NES Huang et al., 2019
SHH Orthotopic xenograft Orthotropic xenograft of iPSC-derived NES from a Gorlin patient with a germline PTCH1 mutation Susanto et al., 2020
SHH PDOX Xenograft of patient-derived tumor cells Brabetz et al., 2018; Smith et al., 2020
Group 3 GEMM Mycn OE, Trp53–/– Swartling et al., 2010
Group 3 GEMM GTML Trp53KI/KI p53ERTAM Hill et al., 2015
Group 3 GEMM Mll4 –/– Dhar et al., 2018
Group 3 GEMM Gfi1 OE + c-MYC OE/Otx2 OE + c-MYC OE Ballabio et al., 2020
Group 3 Orthotopic xenograft Myc OE, Trp53–/– Kawauchi et al., 2012; Pei et al., 2012
Group 3 Orthotopic xenograft MycT58A OE, Trp53 DN Pei et al., 2012

Glioma models

Brain tumor Type of model Features References

Group 3 Orthotopic xenograft Myc OE, GFI1b OE Northcott et al., 2014
Group 3 PDOX Xenograft of patient-derived tumor cells Brabetz et al., 2018; Smith et al., 2020
Group 3 Organoid model Gfi1 OE + c-MYC OE/Otx2 OE + c-MYC OE Ballabio et al., 2020, 2021
Group 4 GEMM Activated SRC OE, Tp53 DN Forget et al., 2018
Group 4 PDOX Xenograft of patient-derived tumor cells Brabetz et al., 2018; Smith et al., 2020

Ependymoma models

Brain tumor Type of model Features References

Ependymoma GEMM RELAFUS1 Ozawa et al., 2018
Ependymoma GEMM YAP1-MAMLD1 Pajtler et al., 2019
Ependymoma GEMM nlsYAP5SA or Lats1–/– and Lats2–/– Eder et al., 2020
Ependymoma PDOX Xenograft of patient-derived tumor cells Brabetz et al., 2018; Smith et al., 2020

Meningioma models

Brain tumor Type of model Features References

Meningioma CLX BenMen1, Me3TSC cell line xenograft Püttmann et al., 2005; Cargioli et al., 2007
Meningioma CLX CH-157-MN cell line xenograft Ragel et al., 2008
Meningioma CLX IOMM-Lee cell line xenograft McCutcheon et al., 2000
Meningioma PDOX Xenograft of patient-derived tumor cells McCutcheon et al., 2000
Meningioma GEMM Nf2 –/– Kalamarides et al., 2002
Meningioma GEMM PDGFB OE + Nf2–/– + Cdkn2ab–/– Peyre et al., 2015
Meningioma GEMM SmoM2 OE Boetto et al., 2018
Meningioma GEMM Nf2–/– + Ink4a–/– Kalamarides et al., 2011
Meningioma PDO Patient-derived organoids Chan et al., 2021; Yamazaki et al., 2021